Coping with increasing medicine costs through greater adoption of generic prescribing and dispensing in Pakistan as an exemplar country (Englisch)
- Neue Suche nach: Abdullah, Saad
- Neue Suche nach: Saleem, Zikria
- Neue Suche nach: Godman, Brian
- Neue Suche nach: Abdullah, Saad
- Neue Suche nach: Saleem, Zikria
- Neue Suche nach: Godman, Brian
In:
Expert Review of Pharmacoeconomics & Outcomes Research
;
24
, 2
;
167-170
;
2024
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Coping with increasing medicine costs through greater adoption of generic prescribing and dispensing in Pakistan as an exemplar country
-
Beteiligte:
-
Erschienen in:Expert Review of Pharmacoeconomics & Outcomes Research ; 24, 2 ; 167-170
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:07.02.2024
-
Format / Umfang:4 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 24, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 167
-
Coping with increasing medicine costs through greater adoption of generic prescribing and dispensing in Pakistan as an exemplar countryAbdullah, Saad / Saleem, Zikria / Godman, Brian et al. | 2024
- 171
-
Alternative approaches to measuring value: an update on innovative methods in the context of the United States Medicare drug price negotiation programDiStefano, Michael J. / Zemplenyi, Antal / Anderson, Kelly E. / Mendola, Nicholas D. / Nair, Kavita V. / McQueen, Robert Brett et al. | 2024
- 181
-
Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countriesKaló, Zoltán / Niewada, Maciej / Bereczky, Tamás / Goettsch, Wim / Vreman, Rick A / Xoxi, Entela / Trusheim, Mark / Callenbach, Marcelien H E / Nagy, László / Simoens, Steven et al. | 2024
- 189
-
The role of insurance policies in the drug pricing landscapeSavova, Alexandra / Manova, Manoela / Tachkov, Konstantin / Petrova, Guenka et al. | 2024
- 203
-
Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholdsGloria, Mac Ardy Junio / Thavorncharoensap, Montarat / Chaikledkaew, Usa / Youngkong, Sitaporn / Thakkinstian, Ammarin / Chaiyakunapruk, Nathorn / Ochalek, Jessica / Culyer, Anthony J. et al. | 2024
- 217
-
Cost-utility analysis of sacituzumab govitecan versus chemotherapy for the treatment of metastatic triple-negative breast cancer in SingaporeCher, Boon Piang / Goh, Sharon / Aziz, Mohamed Ismail Abdul / Wong, Grace / Ng Chee Hui, Raymond / Ong, Benjamin Shao-Kiat / Ng, Kwong-Hoe et al. | 2024
- 227
-
A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in SpainMacía, Manuel / Díaz-Encarnación, Montserrat / Solans-Laqué, Roser / Mallol, Elisenda Pomares / Castells, Alejandra García / Escribano, Cristina / de Arellano, Antonio Ramírez et al. | 2024
- 237
-
Capturing the holistic value of biosimilars in Europe – part 1: a historical perspectiveMestre-Ferrandiz, Jorge / Czech, Marcin / Smolen, Josef S. / Cornes, Paul / Aapro, Matti S. / Danese, Silvio / Deitch, Stephen / Tyldsley, Hannah / Foster, Will / Shah, Pooja et al. | 2024
- 251
-
Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies — can alignment be improved?Wolters, Sharon / de Jong, Lisa A / Jansen, Christel / Jansman, Frank GA / Postma, Maarten J et al. | 2024
- 267
-
Canadian English translation and linguistic validation of the 13-MD to measure global health-related quality of lifePoder, Thomas G. / Touré, Moustapha et al. | 2024
- 273
-
Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in IranBashari, Negin / Safaei Lari, Majid / Darvishi, Ali / Daroudi, Rajabali et al. | 2024
- 285
-
Cost-effectiveness analysis of toripalimab plus chemotherapy for patients with advanced esophageal squamous cell carcinoma in ChinaKang, Shuo / Wang, Xiaohui / Pan, Zhenhua / Liu, Huanlong et al. | 2024
- 293
-
Payer and Developer perspectives on alternative payment modelsMoradian, Renita / Meshesha, Tsega / Trusheim, Mark / Barlow, Jane F et al. | 2024
- 303
-
Social care data in the UK; current landscape, challenges, and future recommendationsMendes, Diana / Wood, Robert / Seif, Monica / Collings, Shuk-Li et al. | 2024
- 315
-
Developing the Lebanese health economic evaluation guidelineDaccache, Caroline / Karam, Rita / Evers, Silvia M.A.A. / Hiligsmann, Mickaël / Rizk, Rana et al. | 2024